This search looks for keywords in all of the website’s content. Search tips
Filter by
VeterinaryRegulatory and procedural guidanceMaximum residue limitResearch and development
The European Medicines Agency's scientific guidelines on biosimilar medicinal products help medicine developers prepare marketing authorisation applications for human medicines.
HumanBiosimilarsRegulatory and procedural guidanceResearch and developmentScientific guidelines
The European Medicines Agency (EMA) publishes assessment reports on maximum residue limits for active substances contained in veterinary medicines, which have been assessed by the EMA's Committee for Medicinal Products for Veterinary Use (CVMP) and are currently pending the adoption of a legally binding Regulation by the European Commission.
VeterinaryRegulatory and procedural guidanceMaximum residue limitMedicinesResearch and development